

HY-P991176 · 1 mg
MedChemExpress · Cat: HY-P991176
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/rg-6333.htmlDescription
RG-6333 is a bispecific agonist targeting CD19 and CD28. RG-6333 specifically recognizes and binds to the CD19 antigen on the surface of B-cell malignancies to locate tumor cells. RG-6333 activates T cells by binding to CD28, overcoming activation barriers to enhance anti-tumor immunity. RG-6333 can be used in the study of relapsed/refractory non-Hodgkins lymphoma. The recommended isotype control is human IgG4 kappa, isotype control HY-P99003 .







